December 8, 2022
Via: Drugs.comA relatively new drug is boosting survival rates for women with a specific type of advanced breast cancer who haven’t responded to other treatments, according to a pair of clinical trials. The targeted antibody drug — trastuzumab deruxtecan (T-DXd, sold […]
February 22, 2022
Via: Natalie DunnAs the Omicron variant of the virus that caused the current pandemic spreads and mutates, people are left hoping this will be the end of the healthcare crisis. Unlike previous variants, Omicron seems to be more infectious but less severe. […]
February 11, 2022
Via: Drugs.comThe U.S. Food and Drug Administration on Friday gave the nod for a new monoclonal antibody treatment that works against the Omicron variant. The emergency use authorization for bebtelovimab is for the treatment of mild to moderate COVID-19 in adults […]
Clinical Trials, Research and Development
November 9, 2020
Via: Genetic Engineering and Biotechnology NewsAccording to the National Cancer Institute, about 10% of patients with pancreatic cancer (PC) remain alive five years after diagnosis. Tumor size has a strong impact on survival rates. The larger the tumor, the less likely it is to be […]
July 19, 2024
July 11, 2024
July 11, 2024
Copyright © 2024. All rights reserved
